Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Johan van Wijgerden"'
Autor:
Katrina Brown, Graham Fraser, Mary Ramsay, Ruth Shanley, Noel Cowley, Johan van Wijgerden, Penelope Toff, Michelle Falconer, Michael Hudson, John Green, J Simon Kroll, Charles Vincent, Nick Sevdalis
Publikováno v:
PLoS ONE, Vol 6, Iss 5, p e19381 (2011)
Continued suboptimal measles-mumps-rubella (MMR) vaccine uptake has re-established measles epidemic risk, prompting a UK catch-up campaign in 2008-09 for children who missed MMR doses at scheduled age. Predictors of vaccine uptake during catch-ups ar
Externí odkaz:
https://doaj.org/article/847a9eb354ea47ffb69572eb5b7d6c84
Autor:
Stefan Edlund, Derryn Lovett, Johan van Wijgerden, Kezban Yagci Sokat, Alan J Poots, James H. Kaufman
To investigate the feasibility of using freeware to model and forecast disease on a local scale, we report the results of modeling measles using a spatial patch model centered around 73 clinics in the North West London Borough of Ealing. MMR1 and MM2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db56499e70a2260fbbfc266f6038dca1
https://doi.org/10.1101/497800
https://doi.org/10.1101/497800
Publikováno v:
Archives of Disease in Childhood. 99:348-353
Objectives To assess childhood vaccination coverage at first, second and fifth birthdays by ethnicity in London between 2006/2007 and 2010/2011 and identify factors relating to lower coverage. Design Data concerning receipt of diphtheria-containing v
Autor:
Michael J. Hudson, Nick Sevdalis, Michelle Falconer, John Green, Katrina F. Brown, Mary Ramsay, Noel A.L. Cowley, J. Simon Kroll, Charles Vincent, Johan van Wijgerden, Graham Fraser, Ruth Shanley, Penelope Toff
Publikováno v:
Vaccine. 29:1700-1709
BACKGROUND AND OBJECTIVE: Parents' attitudes toward MMR vaccine and measles, mumps and rubella infections relate to their child's MMR status, therefore improving these attitudes is central to improving current suboptimal MMR uptake. However, no study
Autor:
Adrian V. S. Hill, Robert J. O. Davies, Helen McShane, Natalie E. R. Beveridge, Nicola Alder, Angela M. Minassian, Geoffrey Pasvol, Fergus V. Gleeson, Ansar A. Pathan, Johan Van Wijgerden, Clare R. Sander, Ian D. Poulton
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 179:724-733
Copyright © 2009 by the American Thoracic Society. Rationale: An effective new tuberculosis (TB) vaccine regimen must be safe in individuals with latent TB infection (LTBI) and is a priority for global health care. Objectives: To evaluate the safety